Receptor-interacting protein 140 (RIP140) is a versatile co-regulator for nuclear receptors and many transcription factors and contains several autonomous repressive domains. RIP140 can be acetylated, and acetylation affects its biological activity. In this study, a comprehensive proteomic analysis using liquid chromatography-tandem mass spectroscopy was conducted to identify the in vivo acetylation sites on RIP140 purified from Sf21 insect cells. Reporter assays were conducted to examine the effects of acetylation on various domains of RIP140. Green fluorescent protein-tagged fusion proteins were used to demonstrate the effect on nuclear translocation of these domains. A general inhibitor of reversible protein deacetylation was used to enrich the acetylated population of RIP140. The amino-terminal region (amino acids (aa) 1-495) was more repressive and accumulated more in the nuclei under hyperacetylated conditions, whereas hyperacetylation reduced the repressive activity and nuclear translocation of the central region (aa 336 -1006). The deacetylase inhibitor had no effect on the carboxyl-terminal region (aa 977-1161) where no acetylation sites were found. Hyperacetylation also enhanced the repressive activity of the fulllength protein but triggered its export into the cytosol in a small population of cells. This study revealed differential effects of post-translational modification on various domains of RIP140 through acetylation, including its effects on repressive activity and nuclear translocation of the fulllength protein and its subdomains. Environmental factors in the extracellular milieu utilize signal transduction pathways to propagate their cues into gene expression (1-3). Often the proteins involved in such signaling pathways undergo post-translational modification. A variety of post-translational modifications, including phosphorylation, acetylation, methylation, and glycosylation, regulate protein functions (4 -7). The study of protein function by identification of proteins along with their post-translational modification has been referred to as "functional proteomics" and is an important step in delineating signal transduction pathways. One major challenge is to identify post-translational modifications on these proteins in vivo (8).Receptor-interacting protein 140 (RIP140) 1 is a co-regulator for many transcription factors (9). Nuclear receptors represent the largest group of transcription factors that interact with RIP140 (10 -13). Human RIP140 was initially characterized as a ligand-dependent co-activator for a chimeric estrogen receptor (10). However, the mouse RIP140 cloned in our laboratory with the ligand-binding domain of an orphan nuclear receptor TR2 as the bait was shown to be a potent corepressor for TR2 in the absence of putative ligand (14). Later many researchers including our group reported RIP140 as a suppressor for nuclear hormone receptors and many other transcription factors (15-17). RIP140 is recruited to nuclear receptors through its nine LXXLL motifs and a modified motif of...